Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Gulam M. Rather, Siang-Yo Lin, Hongxia Lin, Whitney Banach-Petrosky, Kim M. Hirshfield, Chen-Yong Lin, Michael D. Johnson, Zoltan Szekely, Joseph R. Bertino
Published May 25, 2018 · Vol. 9, No. 40 · pp. 25983-25992
Sebastien Rinaldetti, Eugen Rempel, Thomas Stefan Worst, Markus Eckstein, Annette Steidler, Cleo Aaron Weiss, Christian Bolenz, Arndt Hartmann, Philipp Erben
Published May 25, 2018 · Vol. 9, No. 40 · pp. 25935-25945
Federica Mazzuca, Concetta Elisa Onesti, Michela Roberto, Marco Di Girolamo, Andrea Botticelli, Paola Begini, Lidia Strigari, Paolo Marchetti, Maurizio Muscaritoli
Published May 22, 2018 · Vol. 9, No. 39 · pp. 25714-25722
